Member Info for Toyin

Thank you PGlancy, much appreciated.

Farris, that is no defence. What can’t speak can’t lie, it’s in black and white.

Adyan, please read the statement from the half year results issued 2nd April 2020, yes that’s 2020!

“Any licensed products resulting from these agreements will be sold to Croda’s global portfolio of Personal Care customers, which amount to >12,000, some of which are the leading companies and brands in the market. SkinBioTherapeutics will be paid tiered royalties based on global sales revenues on any licensed products subsequently derived from the successful development of the partnership. Recognising the development activity required by Croda, the Company anticipates revenue generation to commence from these additional agreements during 2021.”

Did that sink in, “anticipated revenues during 2021” tell me, what year are we in? Did we get revenues in 2021, no, how about 2022, no, surely we got some in 2023, afraid not. Here we are, November 2024, any revenue now Adyan? And you think I am being impatient!

That right there is one of the reasons Croda’s share price is at a seven year low, I’ve seen galaxies form quicker. Let's not make any more excuses or make things more complicated than what they are, they have until the 20th of this month, thats the five years up and let's also not forget that includes a fecking 12 month extension!!! No more delays, they are four years late, that is a fact!

Oleric, the rise was due to the rns on the 23/10, the subsequent fall, who knows, but the volume has been low. It is possible opti sold approximately 2m shares on the way up which wouldn’t have helped but we had about 14m volume over the three and a half days so should have been soaked up quite easily, they cant have sold anymore or a TR1 would have been issued. Everyone is waiting for the Croda forecasts due Oct/Nov, the five years is up on the 20/11.

If you have anything constructive to add, please feel free, otherwise can you keep your fetish for Elric private.

Mol, I think you need to go and lie down or mow a lawn!🤣

Mol, The 16/10 is irrelevent, the last OPTI TR1 was Friday last week, which was the 25th. Since then these are the facts.

1. He now has .92% of shares avalible to sell down without issuing another TR1, fact.

2. Cenkos, who he has to use to sell the shares have been top of the sell side on level 2 since Monday lunch, fact.

3. We know he has a looming legal bill or two (if PBX come knocking for costs) which will need coving, fact.

4. SOH has openly said he will sell into strength, fact.

As I say, these are the facts.

Dustbin, I disagree. When you have your largest shareholder saying he will "support" us by selling shares into strength, not the smartest thing to say is it? Prospective investors have had plenty of time to buy shares but havent. Every man and his dog is waiting for Croda.

Bufflehead, Cenkos have been top of the sell side since the TR1 on Friday (still there as I type). I posted this yesterday on another board, it may be of interest.

SOH can dump a couple of million shares without issuing a TR1, they have to use Cenkos. Not saying it's him, but these are the facts.

Worth a listen from 12m 50s, pay special attention to his comments @ 14m about the support he is giving us!

https://soundcloud.com/optibiotix-investor/july-28th-2023-podcast-optibiotix-health-plc

Dsymons, what do you mean, "controlled by opti"

I have just gone back through SBTX articles and this came up, the timing is interesting.

Breaking: Email Exchange with Stuart Ashman as his Nomad demands no more interviews

By Tom Winnifrith | Friday 12 January 2024

Since SA has been banned from talking to investors through any other outlet other than IMC in January, the share price has done nothing in what can only be described as a "transformational" time for the company!

Which bright spark came up with the idea to stop comms, oh yes Giles Balleny. Let that sink in and then let me know if you think Balleny has been a good advisor and should he be sacked? I think the company needs to start comms up again, would everyone agree?

Martin in Jan this year we where at 15p the day the acquisition was announced at that point we where forecast to do £250k FY24. As of today we are forecast to do £6.3m FY25 (pre synergies & pre Croda) plus we know Croda have been forward selling since June and we are at 13.5p. On that timeframe the rise doesnt look too impressive does it. The reason for the recent rise was due to the acquisition, from where we were I think 35% is a pathetic effort, bwtfdik!

Ps, death and taxes, guaranteed!

Elric, SOH has previous, Davidson, bold and stupid go hand in hand. Is it opti selling, I dont know, would I be surprised, no. They have to issue a TR1 very soon so we shall find out soon enough.

Erland, you are correct, he took a pay cut when he joined SBTX.

I appreciate the update. Bufflehead, SA wont know if SOH is selling until they receive a TR1, but we shouldn't have to wait long.

Aquae, I agree to a point. SA needs some support from the nomad and the broker to promote the company. How can we be at a lower share price now with revenues of £6.3m, utter madness. We also need to get rid of the association with opti, it doesnt help with the constant possibility of SOH using us as an ATM.

My money is on someones legal fees need coving.

Bazza, we won’t need to wait until April. Remember we get forecasts this month or November and initial revenues before end of December.

Bel, I can assure you whatever you have made and saved is down to you, nothing to do with me. Enjoy your beer but dont worry about a half pint for me, I'm good thanks. You choose to try and make your money by standing on others, thats not how I roll. You keep doing what you do and I will keep doing what I do.

"Agree pennies make pounds, but if royalty comes out at say £500, but we hope to treble it next year, it's not going to cut the mustard.”

Bel, please stop, your killing me!

We know we get double digit royalties on world wide sales (as always let's go with 10%), so based on your £500 projection that means Croda will sell £5000 worth of ingredient in year one (Matrixyl currently sells approximately £400m). They have invested approx €6m, five years, clinical trials, additional IP filings, for £5,000 pa!

If we just take the 12 VIP’s, that would mean each one would be taking £416.66p worth of product pa.🤣🤣🤣. Oh bel thats a blinder, keep em coming.

“He then told us that the company strain submitted to Croda came from a Hans Christian strain and Croda could not use it.”

Firstly Hans Christian was a danish author, I think you mean Christian Hansen A/S a bioscience company. Secondly he didn’t say they couldn’t use it, he said the price shot up and they had to go elsewhere.

Once again belgrano showing his scaremongering tactics, not fully loaded up yet bel, ohh you pesky charlatan.🤣